Literature DB >> 31807951

Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Toshiharu Nagatsu1.   

Abstract

Cognitive behavioral therapy (CBT) for depression and anxiety, established since the 1960s in the USA, and now in Europe, and all over the world has been found to be effective for treating depression in Parkinson's disease (PD). CBT is further developed to acceptance and commitment therapy (ACT) in Europe and the USA. The neural mechanism of CBT or ACT is still under investigation. In Japan, Morita therapy, a psychotherapy founded in 1919 by Masatake (Shoma) Morita, has been used for common mental problems such as anxiety and depression, but rarely for the psychological symptoms in PD. Morita Therapy is in sharp contrast to western CBT in teaching that undesired mental symptoms such as anxiety and depression are natural features of human emotion in health and disease rather than something to control or eliminate, but it is speculated to be similar to ACT in the approach to acceptance but not elimination of mental symptoms. I speculate that the neural basis might be similar in CBT, ACT, and Morita Therapy. In this commentary, a hypothesis is proposed that CBT, ACT, as well as Morita Therapy might be effective for the treatment of the psychological symptoms such as anxiety and depression in PD and in other mental and physical diseases, probably by similar neural mechanisms in the brain.

Entities:  

Keywords:  Acceptance and commitment therapy; Cognitive behavioral therapy; Depression; Morita therapy; Parkinson’s disease

Year:  2019        PMID: 31807951     DOI: 10.1007/s00702-019-02111-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

Authors:  Jeffrey M Lackner; James Jaccard; Laurie Keefer; Darren M Brenner; Rebecca S Firth; Gregory D Gudleski; Frank A Hamilton; Leonard A Katz; Susan S Krasner; Chang-Xing Ma; Christopher D Radziwon; Michael D Sitrin
Journal:  Gastroenterology       Date:  2018-04-25       Impact factor: 22.682

Review 2.  Depression and Anxiety in Parkinson's Disease.

Authors:  Anette Schrag; Raquel N Taddei
Journal:  Int Rev Neurobiol       Date:  2017-07-21       Impact factor: 3.230

Review 3.  The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis.

Authors:  Lars-Göran Ost
Journal:  Behav Res Ther       Date:  2014-08-19

Review 4.  Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy.

Authors:  David Taylor; Nicholas Meader; Victoria Bird; Steve Pilling; Francis Creed; David Goldberg
Journal:  Br J Psychiatry       Date:  2011-03       Impact factor: 9.319

Review 5.  Acceptance and commitment therapy for anxiety and OCD spectrum disorders: an empirical review.

Authors:  Ellen J Bluett; Kendra J Homan; Kate L Morrison; Michael E Levin; Michael P Twohig
Journal:  J Anxiety Disord       Date:  2014-06-23

6.  Personality and Parkinson's disease: A meta-analysis.

Authors:  Gabriella Santangelo; Federica Garramone; Chiara Baiano; Alfonsina D'Iorio; Fausta Piscopo; Simona Raimo; Carmine Vitale
Journal:  Parkinsonism Relat Disord       Date:  2018-01-12       Impact factor: 4.891

7.  Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Jojo Y Y Kwok; Jackie C Y Kwan; M Auyeung; Vincent C T Mok; Claire K Y Lau; K C Choi; Helen Y L Chan
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

8.  Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.

Authors:  Hitomi Kawanishi; Atsushi Sekiguchi; Misako Funaba; Yasushi Fujii; Kazuhiro Yoshiuchi; Hiroe Kikuchi; Keisuke Kawai; Kazushi Maruo; Norio Sugawara; Kenji Hatano; Tomotaka Shoji; Tadahiro Yamazaki; Kenta Toda; Masafumi Murakami; Masayasu Shoji; Chisato Ohara; Yoshitoshi Tomita; Shin Fukudo; Tetsuya Ando
Journal:  Biopsychosoc Med       Date:  2019-06-06

9.  Cognitive Behavioral Group Therapy Reduces Stress and Improves the Quality of Life in Patients with Parkinson's Disease.

Authors:  Anousha Hadinia; Antonia Meyer; Viviane Bruegger; Florian Hatz; Karolina Nowak; Ethan Taub; Elisabeth Nyberg; Rolf-Dieter Stieglitz; Peter Fuhr; Ute Gschwandtner
Journal:  Front Psychol       Date:  2017-01-04

Review 10.  Mindfulness-based stress reduction in Parkinson's disease: a systematic review.

Authors:  G McLean; M Lawrence; R Simpson; S W Mercer
Journal:  BMC Neurol       Date:  2017-05-15       Impact factor: 2.474

View more
  1 in total

Review 1.  Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies.

Authors:  Johannes M Dijkstra; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2021-12-10       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.